Liver resection for liver metastases from nondigestive endocrine cancer: Extrahepatic disease burden defines outcome

Surgery (United States)

Volumn 151, Issue 6, 2012, Pages 851-859

  Andreou, Andreas ^a   Brouquet, Antoine ^a   Bharathy, Kishore G S ^a   Perrier, Nancy D ^a   Abdalla, Eddie K ^a   Curley, Steven A ^a   Glanemann, Matthias ^b   Seehofer, Daniel ^b   Neuhaus, Peter ^b   Vauthey, Jean Nicolas ^a   Aloia, Thomas A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL TUMOR; ADULT; BONE METASTASIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; ENDOCRINE TUMOR; FEMALE; GERM CELL TUMOR; GRANULOSA CELL TUMOR; HEPATIC NONDIGESTIVE ENDOCRINE METASTASIS; HUMAN; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEAL DISEASE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVIEW; SURGICAL MORTALITY; THYROID TUMOR; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 84861606651     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.12.025     Document Type: Article

References (30)

1. E.K. Abdalla, J.N. Vauthey, and L.M. Ellis Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825
2. F.G. Fernandez, J.A. Drebin, D.C. Linehan, F. Dehdashti, B.A. Siegel, and S.M. Strasberg Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) Ann Surg 240 2004 438 447
3. H. Chen, J.M. Hardacre, A. Uzar, J.L. Cameron, and M.A. Choti Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 1998 88 92
4. R.S. Chamberlain, D. Canes, and K.T. Brown Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 2000 432 445
5. J.M. Sarmiento, G. Heywood, J. Rubin, D.M. Ilstrup, D.M. Nagorney, and F.G. Que Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 2003 29 37
6. S.C. Mayo, M.C. de Jong, and T.M. Pawlik Surgical management and emerging therapies to prolong survival in metastatic neuroendocrine cancer Ann Surg Oncol 18 Suppl 3 2010 220 221
7. S. Yedibela, J. Gohl, and V. Graz Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review Ann Surg Oncol 12 2005 778 785
8. D.R. Carpizo, and M. D'Angelica Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease Lancet Oncol 10 2009 801 809
9. R. Adam, L. Chiche, and T. Aloia Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model Ann Surg 244 2006 524 535
10. G. Ercolani, G.L. Grazi, and M. Ravaioli The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases Ann Surg Oncol 12 2005 459 466
11. D. Elias, A. Cavalcanti de Albuquerque, and P. Eggenspieler Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients J Am Coll Surg 187 1998 487 493
12. J. Weitz, L.H. Blumgart, and Y. Fong Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma Ann Surg 241 2005 269 276
13. A. Rinke, H.H. Muller, and C. Schade-Brittinger Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 2009 4656 4663
14. S. Faiss, U.F. Pape, and M. Bohmig Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors: the International Lanreotide and Interferon Alfa Study Group J Clin Oncol 21 2003 2689 2696
15. J.N. Vauthey, T.M. Pawlik, and E.K. Abdalla Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 2004 722 730
16. D. Ribero, E.K. Abdalla, D.C. Madoff, M. Donadon, E.M. Loyer, and J.N. Vauthey Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome Br J Surg 94 2007 1386 1394
17. P. Tauzin-Fin, M. Sesay, P. Gosse, and P. Ballanger Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma Br J Anaesth 92 2004 512 517
18. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
19. P.A. Clavien, J. Barkun, and M.L. de Oliveira The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
20. A. Berruti, M. Terzolo, and P. Sperone Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial Endocr Relat Cancer 12 2005 657 666
21. L.J. Tacon, R.S. Prichard, P.S. Soon, B.G. Robinson, R.J. Clifton-Bligh, and S.B. Sidhu Current and emerging therapies for advanced adrenocortical carcinoma Oncologist 16 2011 36 48
22. N. Mizuno, Y. Kato, Y. Izumi, T. Irimura, and Y. Sugiyama Importance of hepatic first-pass removal in metastasis of colon carcinoma cells J Hepatol 28 1998 865 877
23. P.H. Sugarbaker Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer J Surg Oncol Suppl 3 1993 158 160
24. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
25. T.R. O'Rourke, P. Tekkis, and S. Yeung Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases Ann Surg Oncol 15 2008 207 218
26. L.E. Harrison, M.F. Brennan, and E. Newman Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients Surgery 121 1997 625 632
27. S.A. Earle, E.A. Perez, and J.C. Gutierrez Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis J Am Coll Surg 203 2006 436 446
28. S.K. Reddy, A.S. Barbas, C.E. Marroquin, M.A. Morse, P.C. Kuo, and B.M. Clary Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis J Am Coll Surg 204 2007 372 382
29. R. Adam Developing strategies for liver metastases from colorectal cancer Semin Oncol 34 2007 S7 S11
30. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016